Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nath Bio-Genes (India) Ltd27-01-2017
27-01-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nath Bio-Genes (India) Ltd27-01-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nath Bio-Genes (India) Ltd27-01-2017
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nath Bio-Genes (I) Ltd27-01-2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Nath Bio-Genes (India) Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.27-01-2017
Shareholding for the Period Ended December 31, 2016
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here21-01-2017
Board Meeting Intimation for Results
Nath Bio-Genes (India) Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on January 28, 2017 to take on record the unaudited financial results for the quarter ended December 31, 2016.14-01-2017
Standalone Financial Results, Limited Review Report for September 30, 2016
Nath Bio-Genes (India) Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 201615-11-2016
Postponement of Board Meeting
With reference to the earlier letter dated October 08, 2016 for conveying the intimation of the meeting of the Board of Directors scheduled to be held October 27, 2016 to consider unaudited financial results of the Company for the quarter ended September 30, 2016.Nath Bio-Genes (India) Ltd has now informed BSE that the Company has received information from two of the independent directors about their unavailability for the audit committee...24-10-2016
Shareholding for the Period Ended September 30, 2016
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here21-10-2016